Favorite this paper

Introduction: According to the World Health Organization, cardiovascular diseases are the most lethal in the world and can reach 25 million deaths annually by 2030, being arterial and venous thrombosis the main causes. Antithrombotics drugs have considerable adverse effects and lack of efficacy (less than 1 in 4 patients who use these drugs prevent a new thrombotic event). Natural products are important source for the development of antithrombotic drugs such as heparin, warfarin and others. An anticoagulant property was described for Tropaeolum majus L. (Tropaeolaceae) (T. majus, capuchinha) (Santo et al, Latin Am J Pharmacy, 26, 732, 2007) although there were no reports of possible antiplatelet effects and phytochemical studies of the plant in order to correlate chemical constituents and bioactivity. Therefore, the aim of this study was to evaluate the antiplatelet and anticoagulant effects together with chromatographic analysis of the leaves of T. majus. Methods: Leaves were collected in Teresópolis-RJ, macerated in ethanol:water solvent (9:1) and the hydroethanolic extract submitted to a liquid-liquid fractionation to obtain the fractions: hexane (FHex), dichloromethane (FDichl), in ethyl acetate (FAcEt), butanolic (FBuOH) and aqueous (FAq). Platelet aggregation (PA) was monitored in vitro by the turbidimetric method of Born & Cross (J. Physiol, 168, 178,1963) in citrated human platelet rich plasma (PRP), induced by different agonists (ADP 5 μM, collagen 5 μg/ml, arachidonic acid – AA 200 μM, U46619 3 μM and ristocetin 1.25 mg/ml); Anticoagulant effect was evaluated by means of the prothrombin time (PT), partially activated thromboplastin time (aPTT) and amidolytic assays on factors Xa and thrombin (FIIa) activities. Phytochemical analyzes are performed by the following techniques: gas chromatography coupled to mass spectrometry (GC- MS), liquid phase chromatography coupled to diode arrangement detector (HPLC-DAD), low (MS / MS) and high resolution (q-TOF / MS) mass spectrometry. Results were analyzed by ANOVA One-way for *p<0.05, Bonferroni post-test, n = 4-8. IC50 values were calculated using GraphPad Prism software. Results: Hydroethanolic extract and fractions of T. majus leaves at 100 μg/ml concentration were able to inhibit all agonists induced PA in different extents, varying by 32% to 99% of inhibition. The FBuOH was the most active and effective against all agonists, inhibiting PA induced by collagen (93%), AA (99%), U46619 (96%), ADP (66%) and ristocetin (82%), interfering in the interaction between GPIbα and von Willebrand factor (vWF) for the latter. FBuOH presented IC50 values of 63.5 μg/ml, 68.2 μg/ml and 10.3 μg/ml for collagen, ADP and U46619, respectively. In the coagulation assays, FBuOH, FDichl and FAcEt fractions only at 500 μg/ml concentration showed a slight inhibition of aPTT, suggesting an action in the intrinsic coagulation pathway. Only thrombin (FIIa) activity was affected by FAcEt, FBuOH and FAq showing IC50 values of 92.5 μg/ml, 260 μg/ml and 327 μg/ml, respectively. The chromatographic analysis allowed to identify as major constituents flavonoids as isoquercertin, astragalin (kaempferol-3-O-glicoside), quercetin-3-O-acetylhexoside, kaempferol-3-O-acetylhexoside, phenolic acids such as 3-caffeoylquinic acid and p-coumariloylquinic acids and the glucosinolate glucotropaeolin, present in the extract and in the most active fractions FBuOH, FAcEt and FAq. Conclusions: The present study describes for the first time the antiplatelet activity for Tropaeolum majus L. and the chemical constituents of the leaves. The butanolic fraction (FBuOH) demonstrated a promising antithrombotic effect by inhibiting multiple PA agonists and signaling, as adhesion, activation, release of granules, Thromboxane A2, GPIbα-vWF interactions, activation of GPIIb/IIIa, and prevent venous thrombosis by inhibiting thrombin, the major protease that leads to clot formation. These effects may be related to the presence of flavonoids, phenolic acids and glucotropaeolin found in the more polar and active fractions of T. majus.